Involvement of heterogeneous ribonucleoprotein F in the regulation of cell proliferation via the mammalian target of rapamycin/S6 kinase 2 pathway.
about
Where is mTOR and what is it doing there?Regulation of blood-testis barrier (BTB) dynamics during spermatogenesis via the "Yin" and "Yang" effects of mammalian target of rapamycin complex 1 (mTORC1) and mTORC2.Sex differences in the acute in vivo effects of different human SP-A variants on the mouse alveolar macrophage proteome.A Proteomic Study of Human Merkel Cell Carcinoma.S6 kinase 2 promotes breast cancer cell survival via Akt.In vivo rescue of alveolar macrophages from SP-A knockout mice with exogenous SP-A nearly restores a wild type intracellular proteome; actin involvement.Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis.Development of monoclonal antibodies specific to ribosomal protein S6 kinase 2.Sex differences in the response of the alveolar macrophage proteome to treatment with exogenous surfactant protein-A.Ursolic Acid-Regulated Energy Metabolism-Reliever or Propeller of Ultraviolet-Induced Oxidative Stress and DNA Damage?The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trialsS6K2: The Neglected S6 Kinase Family Member.S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver.Identification of the novel interacting partners of the mammalian target of rapamycin complex 1 in human CCRF-CEM and HEK293 cells.Locus Mapping, Molecular Cloning, and Expression Analysis of rps6kb2, a Novel Metamorphosis-Related Gene in Chinese Tongue Sole (Cynoglossus semilaevis).S6K2-mediated regulation of TRBP as a determinant of miRNA expression in human primary lymphatic endothelial cells.Suppression of c-Myc induces apoptosis via an AMPK/mTOR-dependent pathway by 4-O-methyl-ascochlorin in leukemia cells.Different interactomes for p70-S6K1 and p54-S6K2 revealed by proteomic analysis.S6 kinase 2 is bound to chromatin-nuclear matrix cellular fractions and is able to phosphorylate histone H3 at threonine 45 in vitro and in vivo.RNA-binding proteins as a point of convergence of the PI3K and p38 MAPK pathways.Pharmacological inhibition of S6K1 facilitates platelet activation by enhancing Akt phosphorylation.Signaling pathways involved in the regulation of mRNA translation.Mammalian EAK-7 activates alternative mTOR signaling to regulate cell proliferation and migration.
P2860
Q28305068-1B4289AB-7247-407B-9634-ED1E7AA3CA26Q33863571-CD173C05-EC54-4BA3-B32B-C5CEDE9E4CEFQ34025840-B2435EFC-1C28-4B67-82AB-10D2EE465AC2Q34274250-CE168942-809A-43B5-85DD-21E0F9C829EAQ34762275-6C345404-BCAF-4108-88EF-2C9C6330AD35Q35560012-AFDAF78A-FEC8-4583-9961-1A264FB86F88Q35876634-A64746F3-83D1-4EFB-A441-4B1986F685B0Q36168887-F9A55FCC-DEFE-438B-A131-C4E7933AC1C0Q36604498-B4A7B521-B7E2-4AEF-B408-DFC82331D204Q37636467-A75AC0DC-3C65-49D7-8E20-2C7CAC903D56Q37690538-099E66E3-707E-4324-B81C-6B753BEACFBCQ38125196-FDA5C3AE-ED54-49A1-ABCB-734E2B0B0E6FQ38329337-D39A7034-E18D-47E0-8DA2-4FF4072BF044Q38612792-C40AE258-808B-45EC-87FA-A47F2B34B786Q38639597-A1DB7508-9E66-408A-9068-0F1F4E798F63Q38758450-C62A9D34-9BBB-4A05-86C9-7575E3D7CD28Q38790535-A1C57334-8F11-4EB3-A6F2-EB46C06C8A95Q38834304-71345517-7477-4151-8AFC-31D412E3F200Q39169842-D10A780C-B9C8-491E-A946-A6885E49D2ACQ41998210-88B0DD4E-B5A3-42EE-87E7-5B041325767AQ47275222-59168B4C-7948-4FE2-95C3-3F46480F1372Q54118148-D0CF5D0D-D521-4E5D-AEBC-9FF27D038E4DQ54943035-C4F2F4C5-CC4A-4857-8D99-75CC9733D29E
P2860
Involvement of heterogeneous ribonucleoprotein F in the regulation of cell proliferation via the mammalian target of rapamycin/S6 kinase 2 pathway.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Involvement of heterogeneous r ...... rapamycin/S6 kinase 2 pathway.
@en
Involvement of heterogeneous r ...... rapamycin/S6 kinase 2 pathway.
@nl
type
label
Involvement of heterogeneous r ...... rapamycin/S6 kinase 2 pathway.
@en
Involvement of heterogeneous r ...... rapamycin/S6 kinase 2 pathway.
@nl
prefLabel
Involvement of heterogeneous r ...... rapamycin/S6 kinase 2 pathway.
@en
Involvement of heterogeneous r ...... rapamycin/S6 kinase 2 pathway.
@nl
P2093
P2860
P356
P1476
Involvement of heterogeneous r ...... rapamycin/S6 kinase 2 pathway.
@en
P2093
Andrew Niewiarowski
Dariya Volkova
Eddy T H Goh
Irina R Tsaneva
Michael J Seckl
Nicholas Michael
Nick Totty
Olivier E Pardo
P2860
P304
17065-17076
P356
10.1074/JBC.M109.078782
P407
P577
2010-03-22T00:00:00Z